Pathologic response rate (pCR) and near-pathologic response rate (near-pCR) with docetaxel-carboplatin (TCarb) in early triple-negative breast cancer.

被引：0
|
作者：
Kern, P.
Kolberg, H. C.
Kalisch, A.
Liedtke, C.
Otterbach, F.
Kimmig, R.
Kurbacher, C. M.
机构：
[1] Univ Duisburg Essen, Essen, Germany
[2] Marienhosp Bottrop, Bottrop, Germany
[3] West German Study Grp, Munster, Germany
[4] Univ Munster, D-48149 Munster, Germany
[5] Univ Duisburg Essen, Inst Pathol, Essen, Germany
[6] Univ Duisburg Essen, Dept Gynecol & Obstet, Essen, Germany
[7] Med Ctr Bonn Friedensplatz, Bonn, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
277
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preferential pathologic complete response (pCR) by triple-negative (-) breast cancer to neoadjuvant docetaxel (T) and carboplatin (C)
    Chang, H. R.
    Slamon, D.
    Gornbein, J. A.
    Chung, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Pathologic response to neoadjuvant therapy with nabpaclitaxel plus carboplatin followed by anthracycline regimen in triple-negative breast cancer.
    David Cardenas, Juan
    Esteban, Carmen
    Garcia Carbonero, Iciar
    Rosero, Adriana
    Martinez Barroso, Katherin
    Borrecion Rivilla, Miguel
    Rubio Salvador, Ana Rosa
    Aguilar Anqulo, Paul Martin
    Garcia Avila, Maria
    Ignacio Chacon, Jose
    Ruiz Martin, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Pathologic complete response (pCR) to neoadjuvant treatment (NAT) with carboplatin, nab-paclitaxel and anthracycline in early and locally advanced triple-negative breast cancer (TNBC).
    Miras, Isabel
    Gil, Ana
    Santos-Fernandez, Paloma
    Sanchez-Camacho, Alberto
    Falcon Gonzalez, Alejandro
    Benavent, Marta
    Cejuela Solis, Monica
    Bofill, Salvador
    Flores, Sandra
    Ruiz-Borrego, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Pathologic response to neoadjuvant therapy with nab-paclitaxel plus carboplatin followed by anthracycline regimen in triple-negative breast cancer.
    Cardenas, Juan David
    Martinez, Elia
    Alba, Blanca Lourdes Trujillo
    Esteban, Carmen Esteban
    Salvador, Ana Rosa Rubio
    Barahona, Ana Dominguez
    Romero, Cristina
    Sanchez-Simon, Raquel
    Garcia Avila, Maria
    Ignacio Chacon, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Pathologic complete response rate across triple negative breast cancer subtypes in the IMMUcan study
    Garcia, Andrea Joaquin
    Rediti, Mattia
    Benyagoub, Abdelkader
    Tissot, Stephanie
    Rusakiewicz, Sylvie
    Liechti, Robin
    Marzetta, Flavia
    Penel, Nicolas
    Oliveira, Julio
    Goeminne, Jean-Charles
    Fournel, Pierre
    Capela, Andreia
    Wang, Xiaoxiao
    Vincent, Delphine
    Rothe, Francoise
    Morfouace, Marie
    Hong, Henoch
    Jackson, Donald
    Sotiriou, Christos
    Buisseret, Laurence
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Pathologic complete response (pCR) to predict patients' survival in luminal breast cancer.
    Wang-Lopez, Qian
    Kwiatkowski, Fabrice
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Dubray-Longeras, Pascale
    Van Praagh-Doreau, Isabelle
    Radosevic-Robin, Nina
    Durando, Xavier
    Penault-Llorca, Frederique
    Chollet, Philippe J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival
    Kern, Peter
    Kalisch, Anne
    von Minckwitz, Gunter
    Puetter, Carolin
    Kolberg, Hans-Christian
    Pott, Dirk
    Kurbacher, Christian
    Rezai, Mahdi
    Kimmig, Rainer
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 210 - 217
  • [8] Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response
    Kern, Peter
    Kalisch, Anne
    Kolberg, Hans-Christian
    Kimmig, Rainer
    Otterbach, Friederich
    von Minckwitz, Gunter
    Sikov, William M.
    Pott, Dirk
    Kurbacher, Christian
    CHEMOTHERAPY, 2013, 59 (05) : 387 - 394
  • [9] Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer
    Sean M. Hacking
    Yihong Wang
    Virchows Archiv, 2023, 483 : 765 - 774
  • [10] Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer
    Hacking, Sean M.
    Wang, Yihong
    VIRCHOWS ARCHIV, 2023, 483 (06) : 765 - 774
12345